TyraTech receives Product Registration in UK

TyraTech, Inc, has received notification from the UK regualtory body that their VaMOUSSE!™ head lice product has been registered as a medical device.

The announcement from the UK Medicines and Healthcare Products Regulatory Agency (MHRA) classes VaMOUSSE!™ as a Class I medical device, a designation which requires the lowest level of regulatory oversight.

TyraTech have announced that they expect to begin distribution and sales of VaMOUSSE!™ in the first half of 2013.